Stock Quality:
Last 7 days
-6.3%
Last 30 days
-28.9%
Last 90 days
-26.6%
Trailing 12 Months
-44.3%
SVRA RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2020 | 22.3M | 14.9M | 7.6M | 257.0K |
2019 | 0 | 0 | 0 | 29.6M |
2018 | 15.0M | 22.3M | 0 | 0 |
2017 | 7.7M | 0 | 0 | 0 |
2016 | 140.5K | 227.0K | 313.5K | 400.0K |
2015 | 0 | 0 | 0 | 54.0K |
2010 | 0 | 0 | 0 | 489.0K |
CEO | Mr. Matthew Pauls J.D., M.B.A. |
---|---|
WEBSITE | savarapharma.com |
SECTOR | Healthcare |
INDUSTRY | Biotechnology |
EMPLOYEES | 28 |